Since its launch in 2018, the ADLM Disruptive Technology Award has recognized breakthrough diagnostics from many innovative companies.
Finalists: MS Pen Technologies, Inc. and Vital Biosciences Inc.
Semifinalists: Cardio Diagnostics Holdings, Inc, Eximius Diagnostics Corporation, and Micronoma
Finalists: Biological Dynamics, Inc. and Visby Medical
Semifinalists: Co-Diagnostics, Inc., Cytovale Inc., and FloBio LLC
Finalists: Mammoth Biosciences and MeMed
Semifinalists: numares GROUP Corporation, OncoHost, and Sight Diagnostics
Finalists: Alcediag and Sherlock Biosciences
Semifinalists: Cardea Bio, Geneoscopy, and Zepto Life Technology
Finalists: PixCell Medical and Singlera Genomics
Semifinalists: Bacteromic, COMBiNATi, Newomics, and PCR ONE
Finalists: Ativa Medical and Two Pore Guys
Semifinalists: Brevitest, Druley Lab, miDiagnostics, and PROMISE